Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-10,042
Closed -$19.5K – 233
2024
Q4
$19.5K Sell
10,042
-22,574
-69% -$49.9K ﹤0.01% 203
2024
Q3
$79.6K Buy
+32,616
New +$73.2K 0.02% 203
2024
Q2
– Sell
-22,652
Closed -$56.2K – 207
2024
Q1
$56.2K Hold
22,652
– – 0.02% 205
2023
Q4
$66.3K Buy
22,652
+3,135
+16% +$8.47K 0.02% 186
2023
Q3
$50.4K Buy
19,517
+2,824
+17% +$8.17K 0.02% 170
2023
Q2
$53.1K Sell
16,693
-3,169
-16% -$9.32K 0.02% 193
2023
Q1
$56K Hold
19,862
– – 0.02% 149
2022
Q4
$56.5K Buy
+19,862
New +$57.9K 0.03% 161

Other funds holding ABEV

Aspen Grove Capital's ABEV Position: Q1 2025 in Review

Aspen Grove Capital sold out of Ambev (ABEV) in Q1 2025, closing a stake of 10,042 shares — an estimated $19.5K sold.

Aspen Grove Capital first reported a position in ABEV in Q4 2022 and held it in 8 quarters. The position peaked at $79.6K in Q3 2024. 363 funds tracked by Wall St. Rank hold ABEV as of Q1 2025.

  • Aspen Grove Capital reported no remaining Ambev position as of Q1 2025 after selling out during the quarter.
  • Aspen Grove Capital sold 10,042 Ambev shares in Q1 2025, an estimated $19.5K.
  • Aspen Grove Capital first reported a position in Ambev in Q4 2022 and held it in 8 quarters.
  • Aspen Grove Capital's Ambev position peaked at $79.6K in Q3 2024.
  • 363 funds tracked by Wall St. Rank held Ambev as of Q1 2025.

Based on Aspen Grove Capital's 13F filing for Q1 2025, filed 14 May 2025.